Etanercept biosimilar (PROBIOMED)

依那西普生物类似药 (PROBIOMED)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEtanercept biosimilar (PROBIOMED)
Drug Alias NameEtanercept (PROBIOMED)依那西普生物仿制药 (PROBIOMED)Etanerceptum (PROBIOMED)Infinitam
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionTumor necrosis factor β inhibitorsTumor necrosis factor α inhibitors
TargetsTumor necrosis factor βTumor necrosis factor α
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsArthritis, Rheumatoid
Approved Indications in ChinaN/A
Original Approved Country/TerritoryMexico
Original Approved Date2014/01/01
Country/TerritoryMexico
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesProbiomed
China Registration ClassN/A

Develop Information

Active CompaniesProbiomed
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeL04AB01
Related LinksN/A